[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-365714-105":59,"doc-detail-365714-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","microbiome-in-prostate-cancer-pathogenic-mechanisms-multi-omics-diagnostics-and-synergistic-therapies","Microbiome in prostate cancer - pathogenic mechanisms, multi-omics diagnostics, and synergistic therapies","","Review synthesizes evidence on how the prostate cancer (PCa) microbiome shapes disease initiation and progression, emphasizing microbial imbalance and downstream effects on immune responses, inflammation, and hormone regulation. It details current high-throughput sequencing and metagenomics approaches used to compare cancerous versus healthy prostate tissues and to reveal microbiome-driven mechanisms. The analysis highlights diagnostic and prognostic potential from microbiome-based strategies while calling for further work toward personalized, microbiome-centric PCa management.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/microbiome-in-prostate-cancer-pathogenic-mechanisms-multi-omics-diagnostics-and-synergistic-therapies/365714/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/microbiome-in-prostate-cancer-pathogenic-mechanisms-multi-omics-diagnostics-and-synergistic-therapies/365714.png","ImageObject",300,407,{"name":92,"@type":93},"Alex Sinclair","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-27","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",16,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the main focus of this review on prostate cancer?","Question",{"text":113,"@type":114},"It focuses on interactions between the microbiome and prostate cancer, including how microbial imbalances affect immune responses, inflammation, and hormone levels.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Which research methods are highlighted for microbiome studies in PCa?",{"text":118,"@type":114},"The review emphasizes high-throughput sequencing and metagenomics to compare microbial composition between cancerous and healthy prostate tissues and to explore underlying mechanisms.",{"name":120,"@type":111,"acceptedAnswer":121},"What do the review conclusions suggest about microbiome differences in PCa?",{"text":122,"@type":114},"Substantial microbial differences are reported between prostate tissues of PCa patients and healthy individuals, indicating a potential link to disease progression.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},365714,1790621060,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},1099523882182,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Journal of Cancer Research and Clinical Oncology (2025) 151:178  \n[https://doi.org/10.1007/s00432-025-06187-w](https://doi.org/10.1007/s00432-025-06187-w)  \nMicrobiome in prostate cancer: pathogenic mechanisms, multi‑omics diagnostics, and synergistic therapies  \nChengran Wang1 · Tianqi Dong1 · Xin’ao Rong1 · Yuce Yang1 · Jianhui Mou1 · Jiaqi Li1 · Jianli Ge2 · Xupeng Mu1 · Jinlan Jiang1  \nReceived: 1 October 2024 / Accepted: 31 March 2025 / Published online: 31 May 2025 © The Author(s) 2025  \nAbstract  \nBackground Prostate cancer (PCa) is a leading cause of cancer-related deaths in men, with the microbiome emerging as a significant factor in its development and progression. Understanding the microbiome's role could provide new insights into PCa pathogenesis and treatment.  \nObjective This review aims to explore the interactions between the microbiome and PCa, focusing on microbial imbalancesand their effects on immune responses, inflammation, and hormone levels. It also discusses advanced research techniques and the potential for microbiome modulation in PCa management.  \nMethods The review synthesizes current literature on the microbiome’s role in PCa, highlighting differences in microbial composition between cancerous and healthy prostate tissues. It examines techniques such as high-throughput sequencing and metagenomics and explores the mechanisms through which the microbiome influences PCa.  \nConclusions The review reveals substantial microbial differences in prostate tissues of PCa patients compared to healthy individuals, indicating a potential link between microbiome alterations and disease progression. It highlights the promise of microbiome-based strategies for diagnosis and treatment and underscores the need for further research into personalized, microbiome-centric approaches for PCa management.  \nKeywords Prostate cancer · Microbiome · Diagnosis · Prognostic factors · Therapeutic targets  \nAbbreviations  \nADT Androgen deprivation therapy AR Androgen receptor  \nCRPC Castration-resistant PCa  \nFMT Fecal microbiota transplantation HSPC Hormone-sensitive PCa  \nHT Hormone therapy  \nICI Immune checkpoint inhibitors LH Luteinizing hormone  \nChengran Wang and Tianqi Dong contributed equally to the study.  \n* Xupeng Mu [muxupeng@jlu.edu.cn](muxupeng@jlu.edu.cn)  \n* Jinlan Jiang [jiangjinlan@jlu.edu.cn](jiangjinlan@jlu.edu.cn)  \n1 Department of’ Scientific Research Center, China-Japan Union Hospital of Jilin University, Changchun, 130033, Jilin Province, China  \n2 Orthopaedic Medical Center, The Second Hospital of Jilin University, Changchun 130041, Jilin Province, China  \nMS Mass spectrometry  \nNK Natural killer  \nPAMP Pathogen-associated molecular patterns PCR Polymerase chain reaction  \nPIA Proliferative inflammatory atrophy PRR Pattern recognition receptors  \nPSA Prostate-specific antigen RNS ROS and nitrogen species ROS Reactive oxygen species TAC Transverse aortic constriction  \nIntroduction  \nProstate cancer (PCa) is the second most prevalent cancer and the fifth deadliest cancer among men globally, with approximately 1.4 million new cases and 375,000 deaths reported in 2020 (Sung et al. 2021) . Despite various treatment options, some patients with PCa experience recurrence within 10 years (Rizzo et al. 2022). The complexity of prostate cancer stems from various factors including age, race,  \nfamily history, environmental influences (Ohadian Moghadam and Momeni 2021), microbial infections, and inflammation. Recently, the roles of microorganisms in cancer have garnered considerable attention (Zhang et al. 2025 ; Harmak et al. 2024) .  \nThe human body harbors a vast array of microorganisms such as bacteria, viruses, and fungi, collectively known asthe human microbiome (Oliva et al. 2021) . Microorganisms forming symbiotic relationships with humans are found across the skin, mouth, digestive and respiratory tracts (Costello et al. 2009), significantly influencing human metabolism, tissue development, and defense mechani","cbCaimy0OZvuTeOb","https://ap.wps.com/l/cbCaimy0OZvuTeOb","pdf",4350160,17,"English","# Abstract\n## Background\n## Objective\n## Methods\n## Conclusions\n# Introduction\n## Prostate cancer burden and rationale for microbiome study\n# Fundamental link between the microbiome and PCa\n## Defining the microbiome and its relationship with cancer","[{\"question\":\"What is the main focus of this review on prostate cancer?\",\"answer\":\"It focuses on interactions between the microbiome and prostate cancer, including how microbial imbalances affect immune responses, inflammation, and hormone levels.\"},{\"question\":\"Which research methods are highlighted for microbiome studies in PCa?\",\"answer\":\"The review emphasizes high-throughput sequencing and metagenomics to compare microbial composition between cancerous and healthy prostate tissues and to explore underlying mechanisms.\"},{\"question\":\"What do the review conclusions suggest about microbiome differences in PCa?\",\"answer\":\"Substantial microbial differences are reported between prostate tissues of PCa patients and healthy individuals, indicating a potential link to disease progression.\"}]","Microbiome in prostate cancer - pathogenic mechanisms, multi-omics diagnostics, and synergistic therapies | PDF",1790161960,43,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/338a7165db2f8f1601b2253089d04699.webp",983,1305,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3770a66878d8d26d4df62d7bc21a778e.webp",982,1304,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b6904b1f55567f1406dab02ca42b9282.webp",981,1303,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/098894d2ac2d43f7bda55fe82e8e6e2b.webp",980,1301]